Preparation method of ACE2 anti-idiotypic egg yolk antibody vaccine

A yolk antibody and anti-idiotypic technology, applied in the direction of antibodies, anti-enzyme immunoglobulin, chemical instruments and methods, etc., can solve problems such as weak efficacy, toxic side effects, and retention time in the body

Pending Publication Date: 2020-10-23
西安咸辅生物科技有限责任公司
View PDF4 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0009] The present invention provides a method for preparing an ACE2 anti-idiotype yolk antibody vaccine, which solves the problems in the prior art that the new crown vaccine has a small molecular weight, is not easy to be decomposed when entering the body, has a stable phase difference, remains in the body for a period of time, has weak efficacy, and has toxic and side effects. The problem is to induce the human body to produce ACE2 antibody, combine with ACE2, block the new coronavirus from entering human cells, and play a preventive role against COVID-19. It has a large molecular weight, is not easy to be decomposed when entering the body, has a long retention time in the body, and has strong stability , strong efficacy, technical effect without toxic side effects

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Preparation method of ACE2 anti-idiotypic egg yolk antibody vaccine
  • Preparation method of ACE2 anti-idiotypic egg yolk antibody vaccine
  • Preparation method of ACE2 anti-idiotypic egg yolk antibody vaccine

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0027] A preparation method of ACE2 anti-idiotypic yolk antibody vaccine, the preparation method comprising: uniformly mixing equal volumes of ACE2 protein solution and Freund's incomplete adjuvant to obtain a first mixed solution; using the first mixed solution to prepare anti- ACE2 antibody; after diluting 0.2mL of the anti-ACE2 antibody into 5mL with PBS buffer, mix it with Freund's incomplete adjuvant in equal volume to obtain a second mixed solution with the first concentration; use the second mixed solution Intramuscularly inject laying hens, carry out the first immunization of the first predetermined number of times to the laying hens according to the first predetermined condition; judge whether the laying hens are high-free chickens; if they are high-free chickens, carry out the last time On the third day after the first immunization, high-free eggs were collected for 20 consecutive days; wherein, the high-free eggs were eggs produced by the high-free chickens; the high...

Embodiment 1

[0034] The embodiment of the present invention provides a preparation method of ACE2 anti-idiotypic yolk antibody vaccine, please refer to the attached figure 1 , the preparation method includes steps S100-S1000, specifically:

[0035] Step S100: Mix the ACE2 protein solution and Freund's incomplete adjuvant in equal volumes to obtain the first mixed solution;

[0036] Step S200: using the first mixed solution to prepare anti-ACE2 antibody;

[0037] Specifically, the ACE2 protein is human ACE2 protein, purchased from Beijing Sino Biological Technology Co., Ltd. The incomplete Freund's adjuvant was used to mix with the ACE2 protein solution in equal volumes, and the first mixed solution was obtained after thorough stirring. The first mixed solution was used to prepare anti-ACE2 antibodies, and there were two kinds of anti-ACE2 antibodies, namely rabbit anti-ACE2 antibodies and mouse anti-ACE2 antibodies. Wherein the anti-ACE2 antibody prepared from mice is a mouse anti-ACE2 ...

Embodiment 2

[0116] In order to detect the titer and specificity of the anti-ACE antibody, this embodiment carried out the titer detection and specificity detection of the anti-ACE antibody.

[0117] 1. Potency detection

[0118] In this embodiment, the titer detection of the rabbit anti-ACE2 antibody and the mouse anti-ACE2 antibody is carried out by ELISA method.

[0119] (1) ELISA is used to detect the titer of the rabbit anti-ACE2 antibody, including steps T110-T190, specifically:

[0120] Step T110: Dilute the ACE2 protein to 10 μg / mL with coating buffer, add the diluted ACE2 protein solution into 8 reaction wells, and let stand at room temperature for 1 hour;

[0121] Step T120: Discard the protein solution in the 8 reaction wells, wash the 8 reaction wells three times with PBS, and wash for 3 minutes each time;

[0122] Step T130: Dilute the rabbit anti-ACE2 antibody by 10 1 、10 2 、10 3 、10 4 、10 5 、10 6 , 10 7 、10 8 times, and then added to 8 of the reaction wells respect...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a preparation method of an ACE2 anti-idiotypic egg yolk antibody vaccine. The method comprises the following steps: mixing an ACE2 protein solution with a Freund's incomplete adjuvant to obtain a first mixed solution; preparing an anti-ACE2 antibody by adopting the first mixed solution; diluting the anti-ACE2 antibody, and mixing the diluted anti-ACE2 antibody with the Freund's incomplete adjuvant to obtain a second mixed solution; carrying out first immunization on the laying hens by using the second mixed solution; judging whether the laying hens are high-immunity chickens or not; if the laying hens are the high-immunity chicken, collecting high-immunity eggs; acquiring a first egg yolk solution; removing impurity proteins in the first egg yolk solution to obtainan ACE2 anti-idiotypic egg yolk antibody crude product; and purifying the anti-idiotypic egg yolk antibody crude product to obtain an ACE2 anti-idiotypic egg yolk antibody refined product, and preparing the ACE2 anti-idiotypic egg yolk antibody vaccine. The vaccine can induce a human body to generate an ACE2 antibody which is combined with ACE2 to block new coronavirus from entering human cells, plays a role in preventing COVID-19, and has the technical effects of being large in molecular weight, not easy to decompose when entering the human body, high in stability and free of toxic and side effects.

Description

technical field [0001] The invention relates to the technical field of epidemic prevention, in particular to a preparation method of an ACE2 anti-idiotype egg yolk antibody vaccine. Background technique [0002] So far, there is still no new coronavirus vaccine available in the world, and only a few vaccines have begun clinical research. They are recombinant vaccines, mRNA vaccines, and inactivated vaccines based on adenovirus. Currently, there are dozens of vaccines under research, including DNA vaccines and others besides the ones mentioned above. The above vaccines are all designed for the pathogenic genes S1 and S2 of the new coronavirus, and there is no vaccine designed for the virus receptor ACE2. The preparation of ACE2 polyclonal antibody has been reported, but it is only used for detection. So far, there are no reports of ACE2 anti-idiotype monoclonal antibody vaccine and anti-idiotype yolk antibody vaccine. [0003] The adenovirus vaccine is actually a genetica...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07K16/42C07K16/02C07K16/28C07K16/40C07K16/06A61K39/395A61P31/14
CPCC07K16/4258C07K16/02C07K16/2896C07K16/40C07K16/06A61P31/14C07K2317/33C07K2317/76
Inventor黄威权田超赵锋李丹黄晓文欧阳森
Owner西安咸辅生物科技有限责任公司